Cynthia Ann Moylan | Scholars@Duke

Cynthia Ann Moylan
Assistant Professor of Medicine

My research interests focus on the study of chronic liver disease and primary liver cancer, particularly from nonalcoholic fatty liver disease (NAFLD). As part of the NAFLD Research Team at Duke, I am investigating the role of epigenetics and genetics on the development of advanced fibrosis from NAFLD. The long term goal of our research is to develop non-invasive biomarkers to identify those patients at increased risk for cirrhosis and end stage liver disease in order to risk stratify patients as well as to develop better preventative and therapeutic strategies.

Current Appointments & Affiliations

Assistant Professor of Medicine, Medicine, Gastroenterology, Medicine 2009
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2014

Contact Information

905 S Lasalle St, Gsrb1, DUMC 3256, Durham, NC 27710
Duke Box 3256, 595 Lasalle GSRB 1, Durham, NC 27710
cynthia.moylan@duke.edu (919) 668-0401

Background
Education, Training, & Certifications
- Fellow In Gastroenterology, Medicine, Duke University 2005 - 2009
- Resident, Medicine, Duke University 2002 - 2005
- M.D., University of Miami 2002
Research
Selected Grants
- Duke Training Grant in Digestive Diseases and Nutrition awarded by National Institutes of Health 1988 - 2021
- Epigenetics and the Development of Nonalcoholic Fatty Liver Disease awarded by American College of Gastroenterology 2015 - 2018
- Role of the Stroma in Fibrolamellar Hepatocellular Carcinoma awarded by Fibrolamellar Cancer Foundation 2016 - 2017
- Lumena PSC awarded by Lumena Pharmaceuticals, Inc. 2014 - 2017
- Characterizing Alcohol's Effects on Repair of Liver Injury awarded by National Institutes of Health 2009 - 2012
Publications & Artistic Works
Selected Publications
- Book Sections
  - Moylan, CA, and Murphy, SK. "DNA Methylation: Basic Principles." In Medical Epigenetics, 11-31. July 1, 2016. Full Text
- Conference Papers
  - Patel, YA, Henao, R, Moylan, CA, Guy, CD, Piercy, DL, Diehl, AM, and Abdelmalek, MF. "Vitamin D is Not Associated with Histologic Severity in NAFLD: Results of a Paired Clinical and Hepatic Gene Expression Profile Analysis." October 2016. Link to Item
  - Suzuki, A, Spencer, HJ, Moylan, CA, Dranoff, JA, Abdelmalek, MF, Guy, CD, and Diehl, AM. "Hepatic estrogen transcriptional activity and estrogen receptor a gene expression are negatively correlated with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD)." October 2016. Link to Item
  - Wegermann, K, Henao, R, Pan, Y, Diehl, AM, Abdelmalek, MF, and Moylan, CA. "BCAT1 is Associated with Clinical Decompensation in NAFLD: A Pilot Study." October 2016. Link to Item
  - Henao, R, Hasanaliyeva, N, Bell, LN, Wulff, J, Perichon, R, Moylan, CA, Lu, JT, Guy, CD, Diehl, AM, and Abdelmalek, MF. "Plasma Metabolomic Profiles Predict Advanced Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease." October 2015. Link to Item
  - Hunt, CM, Beste, LA, Ioannou, GN, Lowy, E, Provenzale, DT, Kelley, MJ, Suzuki, A, Moylan, CA, Oloruntoba, OO, Tillmann, HL, Lim, JK, and Ross, D. "Hepatitis B Testing Prior to Administration of Rituximab, Ofatumumab and Obinutuzumab in the National Veterans Affairs Health Healthcare System, 2002-2014." October 2015. Link to Item
  - Moylan, CA, Murphy, SK, Grenier, C, Abdelmalek, MF, and Diehl, AM. "DNA Methylation Profiles of Fibrosis-Associated Gene in Blood Reflects Liver Fibrosis Severity in Human Nonalcoholic Fatty Liver Disease." October 2015. Link to Item
  - Rabatin, A, Hashem, M, Townsend, ML, Bryan, WE, Moylan, CA, Choi, SS, and Naggie, S. "Treatment Outcomes of Veterans with Decompensated Cirrhosis Receiving All Oral Direct Acting Antiviral Hepatitis C Therapy." October 2015. Link to Item
  - Zhu, R, Baker, SS, Moylan, CA, Abdelmalek, MF, Guy, CD, Zamboni, F, Wu, D, Lin, W, Liu, W, Baker, RD, Govindarajan, S, Cao, Z, Farci, P, Diehl, AM, and Zhu, L. "Systematic Analysis of NAFLD Transcriptome Revealed Elevated Expression of Alcohol Metabolizing Genes in Mild and Severe NAFLD Livers." April 2015. Link to Item
  - Naqvi, IA, White, RR, Moylan, CA, Diehl, AM, and Choi, SS. "Abstract 4117: Utilizing RNA aptamers for biomarker discovery in a novel cell culture system for hepatocellular carcinoma." October 1, 2014. Full Text
  - Moylan, CA, Owzar, K, Muir, AJ, Cauchy, F, Belghiti, J, Diehl, AM, and Paradis, V. "Gene Expression and Pathway Analyses Reveal Distinctions Between Hepatocellular Carcinoma Arising in Fibrotic and Non-Fibrotic Nonalcoholic Fatty Liver Disease." May 2014. Link to Item
  - Oloruntoba, OO, Wilder, JM, Smith, AD, Muir, AJ, and Moylan, CA. "The Influence of Race on Patient Preferences and Access to Orthotopic Liver Transplantation and Organ Donation." 2014. Link to Item
  - Urban, TJ, Moylan, CA, Rein, M, Abdelmalek, MF, Goldstein, DB, and Diehl, AM. "Whole Exome Sequencing of Extreme Phenotypes of NAFLD Identifies Potential Genetic Risk Factors for Advanced Hepatic Fibrosis." 2014. Link to Item
  - Chen, Y, Michelotti, GA, Xie, G, Moylan, CA, and Diehl, AM. "Hedgehog-Induced Serine Biogenesis is Required for Activation of Hepatic Stellate Cells." October 2013. Link to Item
  - Garrett, ME, Moylan, CA, Gibson, J, Yang, H, Pang, H, Dellinger, A, Suzuki, A, Tillmann, HL, Guy, CD, Abdelmalek, MF, Murphy, SK, Diehl, AM, Hauser, M, and Ashley-Koch, AE. "Expression QTL analysis of a gene expression signature which predicts advanced non-alcoholic fatty liver disease." October 2012. Link to Item
  - Chan, IS, Philips, GM, Zdanowicz, M, Teaberry, V, Karaca, G, Rangwala, F, Guy, CD, Moylan, CA, Venkatraman, T, Feuerlein, S, Syn, W-K, Jung, Y, Witek, RP, Michelotti, GA, Choi, SS, Merkle, EM, Lascola, C, and Diehl, AM. "HEDGEHOG PATHWAY INHIBITION BY GDC-0449 CAUSES REGRESSION OF HEPATOCELLULAR CARCINOMAS AND IMPROVES LIVER FIBROSIS IN MDR2-DEFICIENT MICE." October 2011. Link to Item
  - Chen, Y, Choi, SS, Michelotti, GA, Moylan, CA, Karaca, G, Zdanowicz, M, Xie, G, Kruger, L, and Diehl, AM. "TRANSITION OF QUIESCENT STELLATE CELLS INTO MYOFIBROBLASTS REQUIRES HEDGEHOG-MEDIATED INDUCTION OF GLYCOLYSIS." October 2011. Link to Item
  - Philips, GM, Chan, IS, Choi, SS, Xie, G, Michelotti, GA, Zdanowicz, M, Teaberry, V, Rangwala, F, Guy, CD, Karaca, G, Venkatraman, T, Feuerlein, S, Moylan, CA, Syn, W-K, Jung, Y, Witek, RP, Merkle, EM, Lascola, C, and Diehl, AM. "HEDGEHOG PATHWAY INHIBITION INDUCES HCC TUMOR NECROSIS BY REPRESSING EXPRESSION OF ANGIOPOIETIN-2 AND ITS COGNATE RECEPTOR, TIE-2." October 2011. Link to Item
  - Tillmann, H, Suzuki, A, Pang, H, Dellinger, A, Guy, CD, Moylan, CA, Piercy, D, Smith, M, Hauser, MA, Diehl, AME, and Abdelmalek, MF. "COFFEE CONSUMPTION INCREASES HEPATIC EXPRESSION OF CYTOCHROME P450S AND SIGNIFICANTLY REDUCES LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)." March 2011. Link to Item
  - Choi, SS, Pereira, TA, Syn, W-K, Agboola, KM, Moylan, CA, Omenetti, A, Karaca, GF, Rangwala, F, Jhaveri, R, and Diehl, AM. "CO-CULTURE OF LIVER EPITHELIAL CELLS STABLY TRANSFECTED WITH HEPATITIS B VIRUS X PROTEIN PROMOTES MYOFIBROBLASTIC ACTIVATION AND ACCUMULATION VIA A HEDGEHOG-MEDIATED PROCESS IN RAT HEPATIC STELLATE CELLS." October 2010. Link to Item
  - Forssen, U, Kobayashi, M, Moylan, CA, Ludema, CM, and Theodore, D. "NASH INCREASES THE RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS ON THE LIVER TRANSPLANT WAITING LIST." October 2010. Link to Item
  - Moylan, CA, Abdelmalek, MF, Pang, H, Dellinger, A, Choi, SS, Omenetti, A, Chen, Y, Hampton, D, Syn, W-K, Suzuki, A, Tillmann, HL, Acharya, CR, Potti, A, Hauser, MA, and Diehl, AM. "SIGNALS FROM THE FIBROTIC LIVER IN PATIENTS WITH NAFLD MAY PROMOTE DIABETES AND OBESITY." October 2010. Link to Item
  - Moylan, CA, Choi, SS, Dellinger, A, Pang, H, Abdelmalek, MF, Hampton, D, Chen, Y, Omenetti, A, Suzuki, A, Tillmann, HL, Acharya, CR, Potti, A, Hauser, MA, and Diehl, AM. "CONSERVED GENE EXPRESSION PATTERNS IN MYOFIBROBLASTIC MURINE AND HUMAN HEPATIC STELLATE CELLS AND NAFLD PATIENTS WITH LIVER FIBROSIS COMPATIBLE WITH EPITHELIAL-TO-MESENCHYMAL LIKE TRANSITION." October 2010. Link to Item
  - Syn, W-K, Choi, SS, Liaskou, E, Karaca, GF, Oo, YH, Pereira, TA, Bhattacharya, SD, Moylan, CA, Agboola, KM, Omenetti, A, Schroder, VT, Mi, Z, Guy, CD, Abdelmalek, MF, Potti, A, Kuo, PC, Michelotti, GA, Adams, DH, and Diehl, AM. "OSTEOPONTIN PROMOTES NONALCOHOLIC FATTY LIVER DISEASE PROGRESSION." October 2010. Link to Item
  - Moylan, CA, Choi, SS, Acharya, CR, Salter, K, Muir, AJ, Potti, A, and Diehl, AM. "GENE EXPRESSION PROFILES COUPLED WITH SIGNATURES OF ONCOGENIC PATHWAY DYSREGULATION PROVIDE A RATIONAL APPROACH TO DISSECTING THE MOLECULAR HETEROGENEITY OF HEPATOCELLULAR CARCINOMA." October 2008. Link to Item
  - Robertson, KD, Moylan, CA, Brady, CW, and Muir, AJ. "Factors influencing participation in hepatitis C research trials." September 2007. Link to Item
- Journal Articles
  - Patel, YA, Henao, R, Moylan, CA, Guy, CD, Piercy, DL, Diehl, AM, and Abdelmalek, MF. "Reply to Kim et al." The American journal of gastroenterology 112, no. 5 (May 2017): 807-808. Full Text
  - Mwinyi, J, Boström, AE, Pisanu, C, Murphy, SK, Erhart, W, Schafmayer, C, Hampe, J, Moylan, C, and Schiöth, HB. "NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition." Biochimica et biophysica acta 1862, no. 3 (March 2017): 314-323. Full Text
  - Patel, YA, Henao, R, Moylan, CA, Guy, CD, Piercy, DL, Diehl, AM, and Abdelmalek, MF. "Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis." The American journal of gastroenterology 111, no. 11 (November 2016): 1591-1598. Full Text
  - Wilder, JM, Oloruntoba, OO, Muir, AJ, and Moylan, CA. "Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 22, no. 7 (July 2016): 895-905. Full Text Open Access Copy
  - "Liver Transplantation for Nonalcoholic Fatty Liver Disease: Role of Bariatric Surgery for Comorbid Obesity." Journal of Advanced Nutrition and Human Metabolism (June 23, 2016). Full Text
  - Hunt, CM, Beste, LA, Lowy, E, Suzuki, A, Moylan, CA, Tillmann, HL, Ioannou, GN, Lim, JK, Kelley, MJ, and Provenzale, D. "Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration." World journal of gastroenterology 22, no. 19 (May 2016): 4732-4740. Full Text Open Access Copy
  - Patel, YA, Berg, CL, and Moylan, CA. "Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation." Digestive diseases and sciences 61, no. 5 (May 2016): 1406-1416. (Review) Full Text
  - Michelotti, GA, Tucker, A, Swiderska-Syn, M, Machado, MV, Choi, SS, Kruger, L, Soderblom, E, Thompson, JW, Mayer-Salman, M, Himburg, HA, Moylan, CA, Guy, CD, Garman, KS, Premont, RT, Chute, JP, and Diehl, AM. "Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches." Gut 65, no. 4 (April 2016): 683-692. Full Text Open Access Copy
  - Michelotti, GA, Tucker, A, Swiderska-Syn, M, Machado, MV, Choi, SS, Kruger, L, Soderblom, E, Thompson, JW, Mayer-Salman, M, Himburg, HA, Moylan, CA, Guy, CD, Garman, KS, Premont, RT, Chute, JP, and Diehl, AM. "Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches." GUT 65, no. 4 (April 2016): 683-692. Full Text Link to Item
  - Zhu, R, Baker, SS, Moylan, CA, Abdelmalek, MF, Guy, CD, Zamboni, F, Wu, D, Lin, W, Liu, W, Baker, RD, Govindarajan, S, Cao, Z, Farci, P, Diehl, AM, and Zhu, L. "Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers." The Journal of pathology 238, no. 4 (March 2016): 531-542. Full Text
  - Machado, MV, Kruger, L, Jewell, ML, Michelotti, GA, Pereira, TDA, Xie, G, Moylan, CA, and Diehl, AM. "Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model." Digestive diseases and sciences 61, no. 1 (January 2016): 137-148. Full Text
  - Schiöth, HB, Boström, A, Murphy, SK, Erhart, W, Hampe, J, Moylan, C, and Mwinyi, J. "A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease." BMC genomics 17 (January 2016): 462-. Full Text
  - Oloruntoba, OO, and Moylan, CA. "Gender-based disparities in access to and outcomes of liver transplantation." World journal of hepatology 7, no. 3 (March 2015): 460-467. (Review) Full Text
  - Karaca, G, Xie, G, Moylan, C, Swiderska-Syn, M, Guy, CD, Krüger, L, Machado, MV, Choi, SS, Michelotti, GA, Burkly, LC, and Diehl, AM. "Role of Fn14 in acute alcoholic steatohepatitis in mice." American journal of physiology. Gastrointestinal and liver physiology 308, no. 4 (February 2015): G325-G334. Full Text
  - Moylan, CA, Pang, H, Michelotti, G, and Diehl, AM. "Reply." Hepatology 60, no. 4 (October 2014): 1445-1446. Full Text
  - Moylan, CA, Pang, H, Michelotti, G, and Diehl, AM. "Reply: To PMID 23913408." Hepatology (Baltimore, Md.) 60, no. 4 (October 2014): 1445-1446. (Letter) Full Text
  - Moylan, CA, Pang, H, Dellinger, A, Suzuki, A, Garrett, ME, Guy, CD, Murphy, SK, Ashley-Koch, AE, Choi, SS, Michelotti, GA, Hampton, DD, Chen, Y, Tillmann, HL, Hauser, MA, Abdelmalek, MF, and Diehl, AM. "Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease." Hepatology 59, no. 2 (February 2014): 471-482. Full Text Link to Item
  - Murphy, SK, Yang, H, Moylan, CA, Pang, H, Dellinger, A, Abdelmalek, MF, Garrett, ME, Ashley-Koch, A, Suzuki, A, Tillmann, HL, Hauser, MA, and Diehl, AM. "Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease." Gastroenterology 145, no. 5 (November 2013): 1076-1087. Full Text Link to Item
  - Garrett, ME, Abdelmalek, MF, Ashley-Koch, A, Hauser, MA, Moylan, CA, Pang, H, Diehl, AM, and Tillmann, HL. "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients." J Hepatol 58, no. 2 (February 2013): 402-403. (Letter) Full Text Link to Item
  - Garrett, ME, Abdelmalek, MF, Ashley-Koch, A, Hauser, MA, Moylan, CA, Pang, H, Diehl, AM, and Tillmann, HL. "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients." Journal of Hepatology 58, no. 2 (2013): 402-403. Full Text
  - Chen, Y, Choi, SS, Michelotti, GA, Chan, IS, Swiderska-Syn, M, Karaca, GF, Xie, G, Moylan, CA, Garibaldi, F, Premont, R, Suliman, HB, Piantadosi, CA, and Diehl, AM. "Hedgehog controls hepatic stellate cell fate by regulating metabolism." Gastroenterology 143, no. 5 (November 2012): 1319-29.e1-11-. Full Text Link to Item
  - Moylan, CA, Suzuki, A, Papay, JI, Yuen, NA, Ames, M, and Hunt, CM. "A pre-marketing ALT signal predicts post-marketing liver safety." Regul Toxicol Pharmacol 63, no. 3 (August 2012): 433-439. Full Text Link to Item
  - Thiele, RH, Williams, J, Moylan, CA, Rao, SV, and Bennett-Guerrero, E. "CASE 6--2012: suspected amiodarone hepatotoxicity after cardiac surgery." J Cardiothorac Vasc Anesth 26, no. 4 (August 2012): 729-732. Full Text Link to Item
  - Acharya, CR, Hsu, DS, Anders, CK, Anguiano, A, Salter, KH, Walters, KS, Redman, RC, Tuchman, SA, Moylan, CA, Mukherjee, S, Barry, WT, Dressman, HK, Ginsburg, GS, Marcom, KP, Garman, KS, Lyman, GH, Nevins, JR, and Potti, A. "Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587." JAMA 307, no. 5 (February 1, 2012): 453-. Full Text Link to Item
  - Philips, GM, Chan, IS, Swiderska, M, Schroder, VT, Guy, C, Karaca, GF, Moylan, C, Venkatraman, T, Feuerlein, S, Syn, W-K, Jung, Y, Witek, RP, Choi, S, Michelotti, GA, Rangwala, F, Merkle, E, Lascola, C, and Diehl, AM. "Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer." PLoS One 6, no. 9 (2011): e23943-. Full Text Open Access Copy Link to Item
  - Syn, W-K, Choi, SS, Liaskou, E, Karaca, GF, Agboola, KM, Oo, YH, Mi, Z, Pereira, TA, Zdanowicz, M, Malladi, P, Chen, Y, Moylan, C, Jung, Y, Bhattacharya, SD, Teaberry, V, Omenetti, A, Abdelmalek, MF, Guy, CD, Adams, DH, Kuo, PC, Michelotti, GA, Whitington, PF, and Diehl, AM. "Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis." Hepatology 53, no. 1 (January 2011): 106-115. Full Text Link to Item
  - Pereira, TDA, Witek, RP, Syn, W-K, Choi, SS, Bradrick, S, Karaca, GF, Agboola, KM, Jung, Y, Omenetti, A, Moylan, CA, Yang, L, Fernandez-Zapico, ME, Jhaveri, R, Shah, VH, Pereira, FE, and Diehl, AM. "Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma." Lab Invest 90, no. 12 (December 2010): 1690-1703. Full Text Open Access Copy Link to Item
  - Choi, SS, Syn, W-K, Karaca, GF, Omenetti, A, Moylan, CA, Witek, RP, Agboola, KM, Jung, Y, Michelotti, GA, and Diehl, AM. "Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway." J Biol Chem 285, no. 47 (November 19, 2010): 36551-36560. Full Text Link to Item
  - Choi, SS, Witek, RP, Yang, L, Omenetti, A, Syn, W-K, Moylan, CA, Jung, Y, Karaca, GF, Teaberry, VS, Pereira, TA, Wang, J, Ren, X-R, and Diehl, AM. "Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells." Hepatology 52, no. 1 (July 2010): 278-290. Full Text Link to Item
  - Choi, SS, Omenetti, A, Witek, RP, Moylan, CA, Syn, W-K, Jung, Y, Yang, L, Sudan, DL, Sicklick, JK, Michelotti, GA, Rojkind, M, and Diehl, AM. "Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis." Am J Physiol Gastrointest Liver Physiol 297, no. 6 (December 2009): G1093-G1106. Full Text Link to Item
  - Moylan, CA, Brady, CW, Johnson, JL, Smith, AD, Tuttle-Newhall, JE, and Muir, AJ. "Disparities in liver transplantation before and after introduction of the MELD score." JAMA 300, no. 20 (November 26, 2008): 2371-2378. Full Text Link to Item
  - Herrenkohl, TI, Sousa, C, Tajima, EA, Herrenkohl, RC, and Moylan, CA. "Intersection of child abuse and children's exposure to domestic violence." Trauma Violence Abuse 9, no. 2 (April 2008): 84-99. (Review) Full Text Link to Item
  - Morpeth, SC, Crump, JA, Shao, HJ, Ramadhani, HO, Kisenge, PR, Moylan, CA, Naggie, S, Caram, LB, Landman, KZ, Sam, NE, Itemba, DK, Shao, JF, Bartlett, JA, and Thielman, NM. "Predicting CD4 lymphocyte count." AIDS research and human retroviruses 23, no. 10 (October 2007): 1230-1236. (Academic Article)
  - Morpeth, SC, Crump, JA, Shao, HJ, Ramadhani, HO, Kisenge, PR, Moylan, CA, Naggie, S, Caram, LB, Landman, KZ, Sam, NE, Itemba, DK, Shao, JF, Bartlett, JA, and Thielman, NM. "Predicting CD4 lymphocyte count <200 cells/mm(3) in an HIV type 1-infected African population." AIDS Res Hum Retroviruses 23, no. 10 (October 2007): 1230-1236. Full Text Link to Item
  - Moylan, CA, and Muir, AJ. "Treatment of hepatitis C in special populations." Clin Liver Dis 9, no. 4 (November 2005): 567-v. (Review) Full Text Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Selected Grants

Selected Publications

Book Sections

Conference Papers

Journal Articles